Date: Feb 15, 2014 Source: PR Newswire (
click here to go to the source)
ST. LOUIS, Feb. 12, 2015 /PRNewswire/ -- Akermin is pleased to announce the issuance of 3 new patents, each contributing to the expansion of the company's intellectual property position in industrial biocatalysis. The United States patent office recently issued Akermin the following patents: US 8895280 Polysilicate-Polysilicone Enzyme Immobilization Materials and US 8859151 Immobilized Enzymes in Biocathodes. The patent office also issued a Notice of Allowance for the company's application on Thiol-ene Coupling Chemistry for Immobilization of Biocatalysts 13/911,275.
These new patents validate the company's focus on creating valuable intellectual property in enzyme delivery technology and system designs through data-supported functional and composition of matter claims. "These new patents expand Akermin's tool box in utilizing biological catalysts for the removal of carbon dioxide from industrial processes" said Alex Zaks, President and CTO of Akermin. "These enzyme delivery vehicles will also support development of broad biocatalyst platforms that Akermin is now pursuing with its partners." These and several other patent applications are under prosecution in many of the major markets around the globe.
About Akermin, Inc.:
Akermin is a clean technology development company located at BRDG Park at the Danforth Plant Science Center in St. Louis, MO. Utilizing its proprietary enzyme delivery technology Akermin is developing industrial biocatalyst approaches that yield lower cost, energy efficient, environmentally benign processes of CO2 management. Additional information is available at the company website: www.akermin.com.
CONTACT:
Barry Blackwell
(314) 669-2611
blackwellb@akermin.com
